OnlyRx review

OnlyRx stands out for identifying the medical team and several dispensing partners on its homepage, while offering both weekly injections and daily orally dissolving tablets. Its entry prices are $179 for semaglutide injections, $249 for semaglutide ODT, $249 for tirzepatide injections and $279 for tirzepatide ODT. Those are starting offers, not a verified flat maintenance price. The oral formats also require a different evidence discussion from approved injections or an approved oral finished product. The platform’s safety page acknowledges that compounded preparations are not FDA-approved and describes a separate branded-prescription referral route where the patient pays a pharmacy independently. OnlyRx is worth comparing if you want named partners and formulation choice, but get the ongoing price, refill mechanics and evidence for the exact formulation before deciding that a tablet is an equivalent substitute.

OnlyRx says it operates a technology platform that connects patients with independent providers through CareGLP rather than practicing medicine or dispensing drugs itself. The homepage identifies Lion MD as the clinical team, led by Ana Lisa Carr, MD, and Kelly Tenbrink, MD, and lists supporting clinicians and NPI numbers. Its named pharmacies are Belmar, Strive Pharmacy, Epiq Scripts and Casa Pharma Rx. These are published disclosures rather than a promise that every listed pharmacy serves every state, dispenses every formulation, or will fill an individual order. The legal terms say OnlyRx does not employ the providers and that independent medical groups remain responsible for treatment decisions. The homepage claims service in all 50 states, while the terms describe availability in certain states and direct patients to support for the current list. A patient should therefore verify the chosen drug and form in their location, especially for an oral compounded preparation.

The process begins with an online medical questionnaire covering health history and weight-loss goals. OnlyRx describes this as a short intake, but the questionnaire does not itself establish that a prescription will be issued. A licensed clinician reviews the information and determines the treatment plan if appropriate, with ongoing support available by email. The homepage’s FAQ puts the full approval-to-delivery process at roughly two to three weeks, so the prominent fast-shipping claim should not be understood as immediate access after answering a few questions. Packaging is described as discreet and shipping is included. Before transferring from another service, ask how the clinician verifies the previous dose and whether records are needed. For either the injection or ODT route, obtain the actual drug name, concentration or tablet strength, administration directions and follow-up schedule directly from the prescriber and dispensing label. These are more useful than the general promise of a personalized program.

OnlyRx advertises no membership or hidden fees, with the consult, prescription process and shipping included in its stated prices. The public product cards show starting prices of $179 for semaglutide injections, $249 for semaglutide ODT, $249 for tirzepatide injections and $279 for tirzepatide ODT. The banner labels the $179 offer as a summer promotion even during this October review. The reviewed public pages do not clearly establish the renewal charge at every dose, the exact duration of a promotional rate, or whether each order is recurring or one-time. That prevents using $179 as a verified maintenance floor. The terms say the amount can vary with the prescribed medication and dispensing pharmacy, with support communicating changes. They also state that medical consult fees are not refundable, prescription products cannot be returned, and sales are final. The site mentions financing and HSA/FSA payment, but financing is a payment arrangement rather than a discount and account eligibility depends on the patient’s plan. For branded medication, OnlyRx’s safety page describes a prescription referral only, with the patient responsible for the pharmacy purchase and all associated costs.

The main catalog contains compounded semaglutide and tirzepatide as weekly injections or daily orally dissolving tablets. A tablet dissolving in the mouth is a distinct preparation: it should not be equated with an FDA-approved branded oral product solely because it contains the same named ingredient. OnlyRx’s safety information says compounded preparations may differ in dosing, absorption, potency and purity and are not FDA-approved. Its prominent clinical-study weight-loss figures do not establish that its own compounded tablets or injections produced those results. Ask the clinician what evidence supports the proposed formulation and why it is appropriate instead of an approved finished medicine. The safety page also discusses an alternative branded-prescription route, explicitly saying OnlyRx does not sell, fulfill or ship the branded drugs. That route needs its own price and pharmacy comparison; the compounded product-card price does not apply to a brand-name prescription. A medical team’s identity and a pharmacy’s license improve traceability but do not independently demonstrate product effectiveness or guarantee individual results.